Home About EMBARC What is EMBARC? Steering Committee International Advisory Board Registry Pharmacy Transparency Notice EMBARC Members Acknowledgements NEWS Latest News Newsletters 2019 Newsletters 2018 Newsletters 2017 Newsletters 2016 Newsletters 2015 RESEARCH Active projects FRIENDS Publications Research Roadmap EDUCATION Assessment and causes Courses and Resources EMBARC Webinar series – ‘Lessons in Bronchiectasis’ Microbiology NTM-lung References Severity assessment Treatment What is Bronchiectasis? Patient Resource Registry Documents EMBARC Registry EMBARC Registry
Current and future pharmacotherapy options for non-cystic fibrosis bronchiectasis. Athanazio R, da Costa JC, de la Rosa Carrillo D, Martínez-García MÁ. Link to publication page: https://www.tandfonline.com/doi/abs/10.1080/17476348.2018.1481392?journalCode=ierx20 Journal Ref: Expert Rev Respir Med. 2018 Jul;12(7):569-584. doi: 10.1080/17476348.2018.1481392. Epub 2018 Jun 14.
